ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China flag China · Delayed Price · Currency is CNY
9.27
+0.06 (0.65%)
Sep 1, 2026, 4:00 PM EDT

ChemPartner PharmaTech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-42.9613.41-226.47-916.75378.59-402.25
Depreciation & Amortization
117.03114.88131.79139.62192.79194.33
Other Amortization
48.1348.5747.7550.3755.5454.4
Loss (Gain) From Sale of Assets
6.30.04-8.4300.150.02
Asset Writedown & Restructuring Costs
3.61.35160.75867.18545.29373.27
Loss (Gain) From Sale of Investments
2.49-12.15-7.80.92-1,391-11.05
Provision & Write-off of Bad Debts
9.2420.4231.244.6616.65.33
Other Operating Activities
24.1216.8623.5244.0332.9385.79
Change in Accounts Receivable
-82.14-89.458.8178.67-107.364.96
Change in Inventory
4.25.927.010.06-16.49-17.13
Change in Accounts Payable
-0.0823.39-41.24-88.55575.229.69
Change in Other Net Operating Assets
91.0254.08----
Operating Cash Flow
165.13190.5168.21150.99262.46378.22
Operating Cash Flow Growth
1.63%13.25%11.40%-42.47%-30.61%10.22%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-68.11-62.47-69.25-201.29-336.2-286
Sale of Property, Plant & Equipment
-29.80.180.160.140.610.41
Divestitures
---36.821,59010
Investment in Securities
20.9-7.871.19150.92-163.65-15.62
Other Investing Activities
26.060.250.230.59-82.780.32
Investing Cash Flow
-50.95-69.9-67.67-12.821,008-210.89

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-87.358.45107.95368.3394.77
Long-Term Debt Repaid
--124.99-131.41-490.05-1,183-549.98
Net Debt Issued (Repaid)
6.45-37.69-72.96-382.1-815.08-155.21
Repurchase of Common Stock
-----5.06-20.44
Common Dividends Paid
-2.74-2.9-2.88-6.24-37.4-81.14
Other Financing Activities
-69.5-39.12-10.6--2.56-2.56
Financing Cash Flow
-60.72-79.71-86.44-388.34-860.11-259.36

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-14.761.157.126.9822.3-0.81
Net Cash Flow
38.742.0321.22-243.19432.43-92.84

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
97.03128.0398.96-50.3-73.7492.22
Free Cash Flow Growth
-13.50%29.37%----
Free Cash Flow Margin
8.34%11.28%10.20%-4.42%-5.56%5.46%
Free Cash Flow Per Share
0.220.290.20-0.10-0.150.19
Levered Free Cash Flow
99.2179.9251.11-76.32-190.3775.59
Unlevered Free Cash Flow
113.4889.8467.42-56.76-148.82124.79

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
-0.170.6---
Cash Income Tax Paid
--13.64-25.4112.02-26.33-0.98
Change in Working Capital
-2.82-12.8915.86-39.04431.5778.38